Consolidated Balance Sheets (Parentheticals) $ in Thousands		Mar. 31, 2025 USD ($) $ / shares shares	Dec. 31, 2024 USD ($) $ / shares shares
Restricted cash, current		$ 14,942	$ 4,850
Notes receivable		146,628	164,562
Deferred tax asset valuation allowance		3,841	3,742
Unamortized debt issuance costs, current		$ 910	$ 1,008
Common stock par value (in usd per share) | $ / shares	[1]	$ 0.00001	$ 0.00001
Common stock authorized (shares) | shares	[1]	750,000,000	750,000,000
Common stock issued (shares) | shares	[1]	35,072,000	34,786,000
Common stock outstanding (shares) | shares	[1]	33,965,000	33,735,000
Treasury stock at cost (shares) | shares	[1]	1,107,000	1,051,000
Variable Interest Entity, Primary Beneficiary
Restricted cash, current		$ 7,088	$ 4,096
Notes receivable		$ 136,106	$ 152,174

[1] Effective March 28, 2025, we performed a 6-for-1 stock split of the Company’s common stock, affected through a stock dividend. Share and per-share amounts have been retroactively adjusted.